Delivery Order SPE2DB22D2006-SPE2DB26FV5SN
Award Date 10/15/25
Potential Completion Date 10/16/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,635.88 delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems on June 26, 2025, with an ultimate completion date of June 27, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Spravato is a specialized neuropsychiatric medication, reflecting the breadth of pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,947.60 on August 27, 2025, for the supply of Spravato 84 mg dose pack unit dose systems. This firm fixed-price delivery order, with a completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract was...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,904.65 on May 27, 2025, for the supply of Spravato 84 mg dose pack unit dose systems (UDS). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Spravato is an FDA-approved nasal spray medication primarily used for treatment-resistant depression, making this a specialized...
- The Defense Logistics Agency awarded a $5,616.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack UDS (unit dose packs) with a completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a specialized nasal spray medication indicated for treatment-resistant depression, representing a critical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product. The contract has a firm fixed price of $8,466.28 and a completion date of April 30, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a medical product, with a ceiling value of $8,812.72. The contract is a firm-fixed price delivery order with a completion date of June 9, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Triescence 40 mg/ml vials, with a ceiling value of $2,392.94 and completion deadline of September 2, 2025. This non-competitive delivery order represents a firm fixed-price procurement utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a $999.9 billion prime vendor agreement...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on September 29, 2025, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order, issued as a child contract under a larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Sprycel 20 mg tablets (quantity 60) with a contract value of $5,063.03 and a completion date of September 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, demonstrating the company's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp on October 3, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's established relationship with the federal...